Emergent Product Development Seattle, LLC
Trubion Pharmaceuticals, Inc. is engaged in advancing biopharmaceutical research and development, focusing on glycosylation, glycoproteomics, and carbohydrate-protein interactions to develop innovative therapeutics and personalized medicine solutions.
Industries
biotechnology
health-care
pharmaceutical
therapeutics
Nr. of Employees
medium (51-250)
Emergent Product Development Seattle, LLC
Seattle, Washington, United States, North America
Products
MicroMolar EDTA assay (colorimetric spectrophotometric kit)
An analytical assay format described for quantifying micromolar concentrations of EDTA in biological, environmental, and industrial samples using a colorimetric reaction measured by spectrophotometry.
MicroMolar EDTA assay (colorimetric spectrophotometric kit)
An analytical assay format described for quantifying micromolar concentrations of EDTA in biological, environmental, and industrial samples using a colorimetric reaction measured by spectrophotometry.
Services
Technical content and domain resources in glycobiology
Publication of educational articles and technical overviews on glycan analysis, glycoengineering, bioconjugation, and related analytical methods to support research planning and interpretation.
Technical content and domain resources in glycobiology
Publication of educational articles and technical overviews on glycan analysis, glycoengineering, bioconjugation, and related analytical methods to support research planning and interpretation.
Expertise Areas
- Glycobiology
- Glycoproteomics
- Glycoengineering
- Glycan mapping and profiling
Key Technologies
- Mass spectrometry (MALDI, ESI)
- High-performance liquid chromatography (HPLC)
- Capillary electrophoresis
- Glycan microarrays